Navigation Links
Optimer Reports Fourth Quarter and Fiscal Year 2011 Financial Results
Date:3/7/2012

SAN DIEGO, March 7, 2012 /PRNewswire/ -- Optimer Pharmaceuticals, Inc. (NASDAQ: OPTR) announced today financial results for the fourth quarter and fiscal year ended December 31, 2011, and provided an update on the DIFICID® (fidaxomicin) launch for the first two months of 2012.

2011 Financial Highlights

  • Total revenues in 2011 were $145 million, compared to $1.5 million in 2010
  • DIFICID net sales in 2011 were $21.5 million, compared to no DIFICID sales in 2010
  • DIFICID net sales in the fourth quarter were $11.0 million

    • "2011 was a highly successful year that saw the FDA approval and U.S. launch of DIFICID as well as European approval. The early launch is highly impactful and we believe interest in DIFICID from physicians, payors and hospitals, coupled with the benefit it can provide patients, will translate into robust growth in product adoption and sales as the launch matures," said Pedro Lichtinger, Optimer's President and CEO. "In 2012 we are starting a series of additional initiatives to support further growth, including a focus on the Long Term Care market, improving access, initiating clinical trials intended to expand our label, and entering new markets including Europe through our collaboration with Astellas and Canada through a direct commercialization effort."

    Fourth Quarter and Fiscal Year 2011 Financials:For the fiscal year 2011 total revenues were $145 million, compared to $1.5 million for the fiscal year 2010. Total revenues for the fourth quarter 2011 were $64.6 million, compared with $156,000 for the fourth quarter 2010. The increases in revenues were primarily due to an upfront payment received from Astellas Pharma Europe in the first quarter and an EMA approval milestone earned in the fourth quarter in connection with the DIFICID license agreement in Europe, as well as the July 18, 2011 commerci
    '/>"/>

    SOURCE Optimer Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Fourth Quarter and FY 2011 Financial Results
    2. Optimer Pharmaceuticals to Present at the 32nd Annual Cowen Health Care Conference
    3. Optimer Pharmaceuticals Provides Update on DIFICID® (fidaxomicin) Tablets Launch
    4. Optimer Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
    5. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
    6. Optimer Pharmaceuticals to Present at BioCentury Newsmakers Conference
    7. Optimer Pharmaceuticals and Astellas Receive Positive Opinion from CHMP for European Approval of DIFICID™
    8. Optimer to Provide DIFICID™ Launch Update at Morgan Stanley Global Healthcare Conference
    9. Optimer Pharmaceuticals DIFICID Featured in 11 Presentations at 51st ICAAC
    10. Optimer Pharmaceuticals to Present at September 2011 Investor Conferences
    11. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/17/2013)... , May 17, 2013  Boehringer Ingelheim ... respiratory disease at the American Thoracic Society International ... , May 17 – 22. ... approved for the treatment of chronic obstructive pulmonary ... as well as investigational compounds for asthma, idiopathic ...
    (Date:5/17/2013)... 2013 Oramed Pharmaceuticals Inc. (NASDAQCM: ... delivery systems, announced today that the United States Food ... New Drug application(IND) for ORMD-0801, its oral insulin capsule. ... FDA clearance to proceed," stated Nadav Kidron ... a major milestone for Oramed and we look forward ...
    (Date:5/16/2013)... and MECHELEN, Belgium , May ... AbbVie (NYSE: ABBV ) announced today an ... Crohn,s disease.  Galapagos will fund and complete a Phase ... facilitate rapid progression into Phase 3.  Upon successful completion ... pay Galapagos $50 million.  The terms of the collaboration ...
    Breaking Medicine Technology:Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6
    ... , WESTBROOK, Maine, Jan. 11 IDEXX ... it placed in excess of 2,000 Catalyst Dx® chemistry ... 2,800. Catalyst Dx, introduced in the first quarter of ... to the IDEXX VetLab® integrated suite of analyzers and ...
    ... , , LAGUNA BEACH, California, January ... irrigated cardiac,ablation systems, announced today that it has completed a ... NBGI Ventures, a venture,capital firm specialized in medical technology investments, ... ACT was founded in 2007 to develop a ...
    Cached Medicine Technology:IDEXX Laboratories Announces Catalyst Dx(R) Placement Total for 2009 and Installed Base of SmartService(TM) Customers 2Advanced Cardiac Therapeutics Completes $5 Million Financing 2Advanced Cardiac Therapeutics Completes $5 Million Financing 3
    (Date:5/18/2013)... New York, New York (PRWEB) May 18, 2013 ... Inc.’s Gynecare pelvic mesh products continue to move forward ... County Superior Court, Bernstein Liebhard LLP reports. According to ... Management Conference in the Ethicon pelvic mesh litigation will ... indicate that 2,755 complaints have been filed in the ...
    (Date:5/18/2013)... FL (PRWEB) May 18, 2013 TheBeautyPlace.com ... Nioxin. Pattern hair loss is not a result of ... According to Men’s Fitness Magazine, 70% of men suffer ... Professional Strength is renowned for hair transplant surgery, ... fights male pattern baldness known as Bosley Professional Strength. ...
    (Date:5/18/2013)... Simple changes in a person’s every day routine, ... water can lead to substantial health benefits, the proven ... Diet Doc understands that overcoming significant weight ... difficult and often requires the use of prescription strength ... get over initial weight loss hurdles. In addition to ...
    (Date:5/18/2013)... 2013 The Ayurvedic practitioner program will ... in the West. Program is available in Mexico via ... a healing modality practiced for over 5,000 years. In ... that health begins when an individual lives in harmony ... individual needs. Ayurveda aims to heal an individual in ...
    (Date:5/18/2013)... Dr. Robert Tracey, an area leader in dental laser ... of the root causes of sleep apnea to provide and ... Sleep Month, Dr. Tracey points out estimates revealing that 40 ... sleep apnea is one of the most common of all. ... breathing at different times while sleeping. When this happens, the ...
    Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 2Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 3Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 2Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce the Best Weight Loss Through New Whole Foods, Healthy Snacks and Prescription Strength hCG Treatments 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce the Best Weight Loss Through New Whole Foods, Healthy Snacks and Prescription Strength hCG Treatments 3Health News:Ayurveda Training in Mexico Offered by Escuela de Ayurveda de California, a Leading Institution in the West 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 2Health News:Pomona, NY Dentist, Dr. Robert Tracey of General & Laser Assisted Dentistry (GLAD) Highlights Sleep Apnea Dentistry Services for Better Sleep Month 3
    ... ... force to promote interest of oil rig crews and other maritime industry employees. , ... Houston, Texas (PRWEB) April 22, 2010 ... illustrates the hazardous and sometimes deadly work conditions that maritime workers face on a daily ...
    ... new options to treat type 1 diabetes, , WEDNESDAY, April ... kind, a wounded soldier whose damaged pancreas had to be ... transplanted back into him, sparing him from a life with ... In November 2009, 21-year-old Senior Airman Tre Porfirio was serving ...
    ... have varying opinions on how much control a person has ... of Iowa researchers suggests that when doctor and patient attitudes ... of taking their medications. Published online and in the ... the study is part of a growing body of ...
    ... can cause pneumonia and meningitis, researchers point out , WEDNESDAY, ... of the PCV7 vaccine to battle bacteria that causes ... notable changes in strains that cause these illnesses, researchers report. ... covered by the vaccine, the team aid. , Immunizations with ...
    ... young viewing audience* and their ideas about gender and violence. ... . Film theorists believe that the action character Lt. ... 1979, paved the way for a new type of female ... see female action characters take part in hand-to-hand combat, wield ...
    ... likely to be screened, study finds , WEDNESDAY, April 21 ... are being screened for skin cancer, a particular problem among ... common cancer screenings, a new study has found. , Researchers ... and older, who took part in the 2005 National Health ...
    Cached Medicine News:Health News:Explosion on Gulf Coast Oil Rig Underscores Daily Dangers for Maritime Workers, Say Houston Maritime Injury Lawyers Arnold & Itkin LLP 2Health News:Wounded Soldier Spared Diabetes With Emergency Transplant 2Health News:Wounded Soldier Spared Diabetes With Emergency Transplant 3Health News:Wounded Soldier Spared Diabetes With Emergency Transplant 4Health News:Patient-physician compatibility increases odds of following doctor's orders 2Health News:Patient-physician compatibility increases odds of following doctor's orders 3Health News:Vaccine Now Misses Many Pneumococcal Infections in Kids 2Health News:Tough girl or sidechick? 2Health News:Few Over 50 Get Skin Cancer Screenings 2
    ... tool for the Humphrey Field Analyzer, ... and shows less inter-test variability than ... degree of reproducibility as Full Threshold ... correlate with the earlier glaucoma damage ...
    ... is the smartest, toughest and most technologically ... on-board artificial intelligence algorithm, DiogenesTM, the Decipher ... while on the patient. The Decipher was ... the rigorous tests required to monitor the ...
    ... is a top quality Carl Zeiss Meditec ... vision defects even safer, more patient-friendly and ... work platform are oriented towards increasing efficiency, ... recovery of vision. Key factors here are ...
    The Vivid e delivers everything you need in a compact echo system, like complete cardiovascular functionality, a comprehensive cardiac measurement and analysis package, and full shared service capabi...
    Medicine Products: